BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TRACON Pharmaceuticals, Inc. 

4510 Executive Drive
Suite 330
San Diego  California  92121  U.S.A.
Phone: 858-550-0780 Fax: 858-550-0786


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
TRACON Pharmaceuticals, Inc. (TCON) Announces Positive Phase 1b Results For TRC105 In Combination With Inlyta (Axitinib) At The ASCO 2015 Genitourinary Cancers Symposium 3/2/2015 7:06:30 AM
TRACON Pharmaceuticals, Inc. (TCON) Appoints Stephen Worland To Its Board Of Directors 2/27/2015 7:41:54 AM
TRACON Pharmaceuticals, Inc. (TCON) Announces Upcoming Presentation Of Results From A Clinical Trial Of TRC105 In Patients With Renal Cell Carcinoma At The American Society of Clinical Oncology 2015 Genitourinary Cancers Symposium 2/20/2015 7:29:06 AM
TRACON Pharmaceuticals, Inc. Announces Pricing Of Initial Public Offering 1/30/2015 7:35:47 AM
TRACON Pharmaceuticals, Inc. Announces Results From A Clinical Trial Of TRC105 In Patients With Hepatocellular Carcinoma To Be Presented At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium 1/9/2015 10:25:14 AM
San Diego Biotech TRACON Pharmaceuticals, Inc. (TCON) Files for $58 Million IPO 12/30/2014 6:15:24 AM
TRACON Pharmaceuticals, Inc. Initiates Randomized Phase 2 Clinical Trial Of TRC105 In Patients With Renal Cell Carcinoma 12/1/2014 10:33:41 AM
TRACON Pharmaceuticals, Inc. Announces Results From Clinical Trials Of TRC105 In Patients With Ovarian Cancer To Be Presented At The 2014 Annual Meeting Of The European Society For Medical Oncology 9/25/2014 7:36:33 AM
San Diego's TRACON Pharmaceuticals, Inc. Reels In $27 Million 9/22/2014 6:01:42 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial Of TRC105 In Patients With Soft Tissue Sarcoma 9/4/2014 10:15:57 AM
1234